Partnerships

AI, Data & Robots (ADRA)

AI, Data & Robots (ADRA)

Partnership website: https://adr-association.eu/

The AI, Data and Robotics (ADR) Partnership is a European initiative that brings together industry, academia, and the European Commission to develop innovative technologies at scale. By pooling resources, expertise, and investments, the partnership aims to generate long-term impact, strengthen European competitiveness, and support job creation and economic growth.

Objectives of the ADR Partnership

The partnership is structured around three main goals:

  • Technological Sovereignty: Strengthen Europe’s control over key technologies and expertise in AI, data, and robotics.
  • Innovation Leadership: Position Europe as a leader in developing technologies with high environmental, social, and economic relevance.
  • Market Competitiveness: Enhance Europe’s global standing in AI, data, and robotics markets.

Why Connect to ADR?

For researchers and entrepreneurs in Flanders, joining the ADR ecosystem offers several advantages:

  • Access to European networks and collaboration opportunities with leading institutions and companies.
  • Participation in Horizon Europe projects, with funding and support for research and innovation.
  • Insight into strategic priorities, helping align local efforts with European goals.
  • Contribution to responsible technology development, guided by European values and principles.

The ADR Partnership promotes trustworthy and value-driven innovation, grounded in fundamental rights and ethical standards. It supports Europe’s ambition to lead globally in the development and deployment of AI, data, and robotics technologies.

What are partnerships?

Partnerships group the EC and private and/or public partners, to coordinate and streamline the research & innovation initiatives and funding in some selected key domains.

More detailed info Overview of partnerships

How to use partnerships?

  • orientation
    Partnerships publish strategic documents, e.g. outlining the main research and innovation challenges or key focus points.
  • networking
    Partnerships often organise events, such as info days, brokerage events, etc. Meet potential partners and learn about the nuances that are not visible in the official documents.
  • ecosystem analysis
    Partnerships typically have an advisory board, and publish impact studies of previous actions. These are good sources of information to uncover the main R&D&I players in the domain.
  • steering the agenda
    Partnerships collaborate with the EC on outlining the strategy and the future funding opportunities in their domain, based on input from industry, academia, and other stakeholders.
Author Do you have an additional question? Or spotted a mistake? Don't hesitate to contact me!
Image of Nico Deblauwe
Nico Deblauwe

nico.deblauwe@vlaio.be

Testimonial

image of Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.

Read the full article Check out the other testimonials 
Logo of VLAIO
Logo of FWO

NCP Flanders

Updates

Our Services

Legal mentions

Privacy Policy
Cookies

LinkedIn